These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 30706119)

  • 21. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.
    Marti C; Garin N; Grosgurin O; Poncet A; Combescure C; Carballo S; Perrier A
    Crit Care; 2012 Jul; 16(4):R141. PubMed ID: 22839689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines to Manage Community-Acquired Pneumonia.
    Wunderink RG
    Clin Chest Med; 2018 Dec; 39(4):723-731. PubMed ID: 30390744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia.
    Hersh AL; Shapiro DJ; Newland JG; Polgreen PM; Beekmann SE; Shah SS
    PLoS One; 2011; 6(5):e20325. PubMed ID: 21655259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT).
    Wiersinga WJ; Bonten MJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; Degener JE; van de Garde EMW; Verheij TJ; Sachs APE; Prins JM
    Neth J Med; 2018 Jan; 76(1):4-13. PubMed ID: 29380739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current status of diagnosis and treatment of community-acquired pneumonia in Shanghai revealed by a questionnaire analysis].
    Liu J; Zhang J; Cheng QJ; Xu JF; Jie ZJ; Jiao Y; Huang Y; Qu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Apr; 41(4):288-295. PubMed ID: 29690685
    [No Abstract]   [Full Text] [Related]  

  • 26. Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study.
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Tokioka F; Yamazaki A; Washio Y; Irie H; Otake T
    J Infect Chemother; 2021 Oct; 27(10):1447-1453. PubMed ID: 34147355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a Community-Acquired Pneumonia Score To Improve Empiric Antibiotic Selection at an Academic Medical Center.
    Oliver MB; Fong K; Certain L; Spivak ES; Timbrook TT
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic Resistance in Community-Acquired Pneumonia Pathogens.
    Wunderink RG; Yin Y
    Semin Respir Crit Care Med; 2016 Dec; 37(6):829-838. PubMed ID: 27960207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V
    Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia.
    Amati F; Bindo F; Stainer A; Gramegna A; Mantero M; Nigro M; Bussini L; Bartoletti M; Blasi F; Aliberti S
    Adv Respir Med; 2023 May; 91(3):224-238. PubMed ID: 37366804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New testing guidelines for community-acquired pneumonia.
    Losier A; Dela Cruz CS
    Curr Opin Infect Dis; 2022 Apr; 35(2):128-132. PubMed ID: 35245248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methicillin-resistant Staphylococcus aureus in community-acquired and health care-associated pneumonia: incidence, diagnosis, and treatment options.
    Dean N
    Hosp Pract (1995); 2010 Feb; 38(1):7-15. PubMed ID: 20469619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-Acquired Pneumonia in Adults: Diagnosis and Management.
    Kaysin A; Viera AJ
    Am Fam Physician; 2016 Nov; 94(9):698-706. PubMed ID: 27929242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for community-onset pneumonia caused by drug-resistant pathogens: A prospective cohort study.
    Barreto JV; Dias CC; Cardoso T
    Eur J Intern Med; 2022 Feb; 96():66-73. PubMed ID: 34670681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
    J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in antibiotic therapy for community-acquired pneumonia.
    Viasus D; Garcia-Vidal C; Carratalà J
    Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-acquired methicillin-resistant Staphylococcus aureus pneumonia: a clinical audit.
    Thomas R; Ferguson J; Coombs G; Gibson PG
    Respirology; 2011 Aug; 16(6):926-31. PubMed ID: 21382130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of community-acquired pneumonia.
    Bartlett J
    Chemotherapy; 2000; 46 Suppl 1():24-31. PubMed ID: 10810210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?
    Guillamet CV; Vazquez R; Noe J; Micek ST; Kollef MH
    Medicine (Baltimore); 2016 Aug; 95(35):e4708. PubMed ID: 27583907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftobiprole medocaril for the treatment of community-acquired pneumonia.
    Falcó V; Burgos J; Almirante B
    Expert Opin Pharmacother; 2018 Sep; 19(13):1503-1509. PubMed ID: 30198789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.